Teladoc Health has fallen ~50% from the highs as major competition enters the telemedicine space. Analysts have cut out year revenue estimates by substantial amounts. Despite the dip below $160, the stock still trades at a forward EV/S multiple of 10x. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.
Trending:
Teladoc Health: Not turning the corner yet